A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jian Zhang
Fudan University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Second Hospital of Anhui Medical University
Hefei, Anhui, China
Recruiting - Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
Recruiting - Huizhou First Hospital
Huizhou, Guangdong, China
Recruiting - Guangxi Medical University Cancer Hospital
Nanning, Guangxi, China
Recruiting - the First Affiliated Hospital of Henan University of Science & Technology
Luoyang, Henan, China
Recruiting - Xinxiang Central Hospital
Xinxiang, Henan, China
Recruiting - Henan Cancer Hospital
Zhengzhou, Henan, China
Recruiting - the First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Not, yet, recruiting - Hubei Cancer Hospital
Wuhan, Hubei, China
Not, yet, recruiting - the Central Hospital of Yongzhou
Yongzhou, Hunan, China
Recruiting - Jiangsu Province Hospital
Nanjing, Jiangsu, China
Recruiting - Jilin Cancer Hospital
Changchun, Jilin, China
Recruiting - the First Hospital of Jilin University
Changchun, Jilin, China
Recruiting - First Affiliated Hospital of China Medical University
Shenyang, Liaoning, China
Recruiting - Liaoning Cancer Hospital & Institute
Shenyang, Liaoning, China
Recruiting - Shandong Cancer Hospital
Jinan, Shandong, China
Recruiting - Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Recruiting - Sichuan Cancer Hospital
Chengdu, Sichuan, China
Recruiting - the Second People'S Hospital of Yibin
Yibin, Sichuan, China
Recruiting - Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China
Recruiting - Sir Run Run Shaw Hospital,affiliated With Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Recruiting - Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Sept 2023
- Primary completion
- 31 Mar 2026
- Completion
- 31 Mar 2028
- Last update posted
- 10 Feb 2026
- Registered enrollment
- 99
- Registry id
- NCT06064812
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.